About
Hemant Surgical Industries Limited manufactures, markets, imports, and exports surgical products, healthcare products & medical equipment and pharmaceutical products in India and internationally. The company offers healthcare & surgical disposables, includes jms meditape, infusion sets, scap vein set, blood transfusion set, pediatric iv, burette set, safecath silicone foley catheter, endotracheal tube, latex foley catheter, feather skin grafting blade, aero skin stapler, aero plus ecg electrodes, digital thermometer, nebulizer, and oxygen concentrator; and dialysis products, such as dialysis machine, refurbish dialysis machine, heparin, diaclean, citro h, iron sucrose injection, dialyzer, bicart, bibag, bloodline tubing, infusion set, bicarbonate mixture, ro plant, water tank, dialysis bed, dialysis chair, refurb ng dialysis machine, av fistula, on & off kit, lumen catheter, and hemodialysis concentrator. The company also offers radiology & criticare products, such as ultrasouch machine, digital radiography machine, X-ray machine, anesthesia machine, multipara monitor, ecg machine, defibrillator, and icu ventilator; and opthalmology products, including galilean and prismatic loupe, spot illuminator, surgical camera, ttl loupe, light source, slit lamp microscope, and operating microscope. In addition, the company offers surgical disposables, such as meditapes, intravenous infusion sets, and oximeters. Further, it provides a turnkey dialysis center, imaging and diagnostic center, modular intensive care unit, modular operation theater, oncology labs and treatment centers, blood bank, and dental clinic setup services. Hemant Surgical Industries Limited was founded in 1985 and is headquartered in Mumbai, India.
Quarterly Results
No quarterly results synced yet for this stock.
Data is backfilled from screener.in — check back soon.Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 231.00 | 107.00 | 106.00 | 109.00 | 101.00 | 60.00 | 56.00 | 56.00 | 51.00 |
| Expenses | 208.00 | 97.00 | 95.00 | 98.00 | 95.00 | 57.00 | 53.00 | 53.00 | 48.00 |
| Operating Profit | 23.00 | 9.00 | 10.00 | 11.00 | 6.00 | 3.00 | 3.00 | 3.00 | 2.00 |
| OPM % | 10.00 | 9.00 | 10.00 | 10.00 | 6.00 | 5.00 | 4.70 | 4.80 | 4.90 |
| Other Income | 6.00 | 5.00 | 4.00 | 2.00 | 2.00 | 1.00 | 0.00 | 0.00 | 0.00 |
| Interest | 4.00 | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 |
| Depreciation | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 1.00 | 0.00 |
| Profit before tax | 24.00 | 11.00 | 13.00 | 10.00 | 6.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Tax % | 23.00 | 23.00 | 23.00 | 24.00 | 25.00 | 9.00 | 41.00 | 8.00 | 10.00 |
| Net Profit | 18.00 | 8.00 | 10.00 | 8.00 | 5.00 | 1.00 | 0.00 | 1.00 | 1.00 |
| EPS in Rs | 13.98 | 7.79 | 9.39 | 9.95 | 248.92 | 73.43 | 27.00 | 61.02 | 50.76 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13.00 | 10.00 | 10.00 | 8.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Reserves | 124.00 | 53.00 | 44.00 | 16.00 | 11.00 | 8.00 | 5.00 | 6.00 | 5.00 |
| Borrowings | 50.00 | 31.00 | 7.00 | 7.00 | 10.00 | 14.00 | 14.00 | 11.00 | 9.00 |
| Other Liabilities | 87.00 | 54.00 | 38.00 | 34.00 | 32.00 | 15.00 | 23.00 | 14.00 | 12.00 |
| Total Liabilities | 274.00 | 148.00 | 100.00 | 65.00 | 54.00 | 40.00 | 44.00 | 33.00 | 28.00 |
| Fixed Assets | 53.00 | 40.00 | 18.00 | 13.00 | 12.00 | 11.00 | 10.00 | 8.00 | 7.00 |
| CWIP | 0.00 | 12.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 1.00 | 5.00 | 0.00 | 1.00 | 0.00 | 1.00 | 0.00 | 0.00 |
| Other Assets | 220.00 | 94.00 | 77.00 | 51.00 | 42.00 | 29.00 | 33.00 | 25.00 | 21.00 |
| Total Assets | 274.00 | 148.00 | 100.00 | 65.00 | 54.00 | 40.00 | 44.00 | 33.00 | 28.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -32.00 | 9.00 | -4.00 | 6.00 | 12.00 | -4.00 | 2.00 | 0.00 | 0.00 |
| Cash from Investing Activity | -3.00 | -30.00 | -12.00 | -3.00 | 0.00 | -2.00 | -2.00 | 0.00 | 0.00 |
| Cash from Financing Activity | 69.00 | 18.00 | 21.00 | -1.00 | -8.00 | 5.00 | 2.00 | 0.00 | 0.00 |
| Net Cash Flow | 34.00 | -4.00 | 5.00 | 3.00 | 4.00 | -2.00 | 2.00 | 0.00 | 0.00 |
| Free Cash Flow | -34.00 | -25.00 | -13.00 | 2.00 | 12.00 | -7.00 | -1.00 | 0.00 | 0.00 |
| CFO/OP % | -118.00 | 126.00 | -9.00 | 84.00 | 197.00 | -127.00 | 68.00 | 0.00 | 0.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 106.00 | 70.00 | 75.00 | 58.00 | 56.00 | 26.00 | 35.00 | 36.00 | 35.00 |
| Inventory Days | 120.00 | 205.00 | 99.00 | 67.00 | 57.00 | 113.00 | 125.00 | 73.00 | 64.00 |
| Days Payable | 146.00 | 188.00 | 116.00 | 110.00 | 92.00 | 89.00 | 143.00 | 97.00 | 102.00 |
| Cash Conversion Cycle | 80.00 | 87.00 | 58.00 | 15.00 | 21.00 | 51.00 | 17.00 | 12.00 | -3.00 |
| Working Capital Days | 24.00 | 61.00 | 52.00 | 2.00 | -19.00 | 41.00 | -28.00 | 23.00 | 12.00 |
| ROCE % | 20.00 | 16.00 | 30.00 | 45.00 | 32.00 | 14.00 | 12.00 | 15.00 | — |
Corporate Actions
No corporate actions recorded.
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update9 Apr from icra
-
Rating update10 Apr 2025 from fitch
-
Rating update22 Jan 2025 from icra
-
Rating update15 Oct 2024 from icra
-
Rating update30 Aug 2024 from icra
-
Rating update15 May 2024 from fitch